Evolving role of mitomycin-C laryngology

Topical mitomycin-C, a chemotherapeutic agent and a fibroblast inhibitor, has been successfully used in larynx, primarily to treat stenosis. Subglottic, tracheal, and anterior glottic stenosis have all shown promising results in a canine model. Less favorable results have been obtained when topical mitomycin-C is used on the vocal folds following surgical excision of mucosa. In the vocal fold studies, laryngeal videostroboscopy revealed diminished mucosal wave vibration in the vocal folds treated with mitomycin-C as well as a more atrophic appearance to the vibratory surface. The tissue treated with mitomycin-C showed fewer fibroblasts and less collagen. However, inflammatory infiltrate was not significantly different between the treated and untreated tissue. These results are consistent with the known suppression of fibroblast proliferation by mitomycin-C. In contrast to the positive effects of mitomycin-C on stenosis, the observed decrease in the healing response in the vocal fold had negative consequences on vocal fold vibratory pattern.

[1]  L. Reinisch,et al.  Effect of Mitomycin-C on Vocal Fold Healing in a Canine Model , 2001, The Annals of otology, rhinology, and laryngology.

[2]  D. Shin,et al.  Mitomycin and the human corneal endothelium. , 1994, Archives of ophthalmology.

[3]  J. Pe’er,et al.  Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia. , 1996, Archives of ophthalmology.

[4]  L. Reinisch,et al.  Preservation of Function and Histologic Appearance in the Injured Glottis With Topical Mitomycin‐C , 1999, The Laryngoscope.

[5]  S. Palmer,et al.  Mitomycin as adjunct chemotherapy with trabeculectomy. , 1991, Ophthalmology.

[6]  P. Hou,et al.  Dacryocystorhinostomy with intraoperative mitomycin C. , 1997, Ophthalmology.

[7]  C. W. Chen.  ENHANCED INTRAOCULAR PRESSURE CONTROLLING EFFECTIVENESS OF TRABECULECTOMY BY LOCAL APPLICATION OF MITOMYCIN C , 1983 .

[8]  R. Eliashar,et al.  Can Topical Mitomycin Prevent Laryngotracheal Stenosis? , 1999, The Laryngoscope.

[9]  H. Kitano,et al.  Intraoperative Mitomycin C in Endolymphatic Sac Surgery for Ménière’s Disease: A Pilot Study , 1999, ORL.

[10]  J. Salmon,et al.  The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. , 1995, Ophthalmology.

[11]  M. Wilson,et al.  Mitomycin eye drops as treatment for pterygium. , 1988, Ophthalmology.

[12]  P. Khaw,et al.  Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. , 1993, Archives of ophthalmology.

[13]  S. Shapshay,et al.  Sinus Surgery: Does Mitomycin C Reduce Stenosis? , 1998, The Laryngoscope.

[14]  L. Reinisch,et al.  Inhibition of Subglottic Stenosis with Mitomycin-C in the Canine Model , 1999, The Annals of otology, rhinology, and laryngology.

[15]  P. Batra,et al.  Preventing Myringotomy Closure with Topical Mitomycin C in Rats , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[16]  L. Reinisch,et al.  Prevention of Anterior Glottic Restenosis in a Canine Model with Topical Mitomycin-C , 2001, The Annals of otology, rhinology, and laryngology.

[17]  S. Estrem,et al.  Preapplication of Mitomycin C for Enhanced Patency of Myringotomy , 2000, Otolaryngology Head & Neck Surgery.

[18]  J. Pederson,et al.  Intermediate-term outcome of variable dose mitomycin C filtering surgery. , 1997, Ophthalmology.